Recruiting
Phase 2

Innovative Therapies

Sponsor:

PPD DEVELOPMENT, LP

Code:

NCT06703073

Conditions

Acute Respiratory Distress Syndrome (ARDS)

ARDS

ARDS (Acute Respiratory Distress Syndrome)

Acute Respiratory Distress Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cohort A: vilobelimab

Cohort A: placebo

Cohort B: paridiprubart

Cohort B: placebo

Cohort C: bevacizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by PPD DEVELOPMENT, LP on 2025-04-04.